Mirum Pharmaceuticals, Inc.
SEC Filing List
MIRM CIK: 0001759425
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Mirum Pharmaceuticals, Inc. | 05/06/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Mirum Pharmaceuticals, Inc. | 05/06/2026 | ||
| 8-K | Current report filing | Mirum Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| SCHEDULE 13G/A | 04/27/2026 | ||||
| 8-K | Current report filing | Mirum Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/27/2026 | |
| ARS | Annual report to security holders | Mirum Pharmaceuticals, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/24/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Mirum Pharmaceuticals, Inc. | 04/23/2026 | ||
| DEF 14A | Definitive proxy statements | Mirum Pharmaceuticals, Inc. | 04/23/2026 | ||
| 4 | Statement of changes in beneficial owner... | Ramasastry Saira | Mirum Pharmaceuticals, Inc. | 04/16/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 04/15/2026 | ||
| No record found. | |||||
| Load More | |||||
